Audio By Carbonatix
German drugmaker BioNTech plans to develop its first malaria vaccine and begin clinical trials by next year.
The ambitious turnaround time is thanks to the MRNA technology used to develop the Pfizer and Moderna coronavirus vaccines in under a year.
The only approved malaria vaccine, Mosquirix, took scientists at GlaxoSmithKline more than 30 years to develop.
Malaria kills more than 400,000 people annually, most of them children in sub-Saharan Africa.
Apart from vaccines and pills, countries - including Malawi, Tanzania and Kenya - use drones to find mosquito breeding grounds and kill the larvae before they hatch.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
Communities applaud early gains under Damang Gold Mine Limited
7 minutes -
Cheddar’s application thrown out, High Court awards GH¢20,000 costs against him in Cola Holdings case
10 minutes -
Court gives Adu-Boahene, wife 6 days to secure lawyers or cross-examine witness themselves
12 minutes -
Investigate alleged US$1.7bn loss in connection with Gold Purchase Programme – Abena Osei Asare to Mahama
14 minutes -
Political parties, judiciary need reforms to protect African democracy — Asiedu Nketiah
16 minutes -
GAUA strike: NLC says administrators may have breached procedure for industrial action
17 minutes -
Photos: Republic Bank, The Multimedia Group sign 3-year deal to launch JoyNews Habitat Fair partnership
19 minutes -
Continuity: The engine of compounding
23 minutes -
AI offer lifeline to developing economies in an era of weak growth – World Bank
33 minutes -
Forefathers built better roads with less education than today’s educated generation – Prof Bokpin
35 minutes -
Kayayei interventions must go beyond skills training – Vice President
39 minutes -
Former Nandom MP Ambrose Dery declares intention to contest again in 2028
47 minutes -
GSE delivers 75% year-to-date return for investors as of July 2026
50 minutes -
IDEG: NDC, NPP disagreement over local elections hindering decentralisation reforms
54 minutes -
Wontumi appeal has no reasonable chance of success – AG opposes bail application
56 minutes